Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma
Henan Cancer Hospital
Henan Cancer Hospital
GenomeFrontier Therapeutics TW Co., Ltd.
The Lymphoma Academic Research Organisation
Ain Shams University
Pell Bio-Med Technology Co., Ltd.
Durham VA Medical Center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Ruijin Hospital
University Medical Center Goettingen
Gruppo Italiano Malattie EMatologiche dell'Adulto
Peking Union Medical College Hospital
Incyte Biosciences Italy S.r.l
Florida International University
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Columbia University
Mayo Clinic
Children's Oncology Group
SWOG Cancer Research Network
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)